Prealbumin: A New Biomarker for Predicting Prognosis in Patients with Severe COVID-19
| Autor: | Selcuk Yaylaci, Ahmed Bilal Genc, İlhan Yıldırım, Kubilay İşsever, Ahmed Cihad Genc, Deniz Çekiç |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Turkey Procalcitonin chemistry.chemical_compound Internal medicine Intensive care medicine Risk of mortality Humans Prealbumin Aged Retrospective Studies SARS-CoV-2 business.industry COVID-19 Retrospective cohort study General Medicine Odds ratio Prognosis Intensive Care Units C-Reactive Protein chemistry Biomarker (medicine) Uric acid Female Biostatistics business Biomarkers |
| Zdroj: | Journal of the College of Physicians and Surgeons Pakistan. 31:S99-S103 |
| ISSN: | 1681-7168 1022-386X |
| Popis: | OBJECTIVE: To analyse whether prealbumin could be a new biomarker for predicting mortality in severe COVID-19 patients. STUDY DESIGN: An observation study. PLACE AND DURATION OF STUDY: Intensive care units (ICU) of Sakarya University Training and Research Hospital, Sakarya, Turkey, from October 2020 to December 2020. METHODOLOGY: The data of 149 patients, who were admitted to the ICU were collected and analysed retrospectively. Routine blood samples were collected from all patients at the time of admission to the ICU; and 102 patients with the mortal course and 47 patients with the non-mortal course were included in the study. The data obtained from these patients were analyzed in the biostatistics programme. Results: The median age of all patients was 68 years; while 94 of them were males (63.1%) and 55 of them were females (36.9%). Median levels of potassium (K) (p=0.04), uric acid (p=0.001), C-reactive protein (CRP) (p=0.004), and procalcitonin (PCT) (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|